ArticleJournal of clinical and translational hepatology2020
A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01).
Open access · diamondAbstract read
In one paragraph
Article in Journal of clinical and translational hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 23 citations in OpenAlex.
- Trends in clinical intervention practice for preventing mother-to-child transmission of hepatitis B virus in Guangdong Province, 2021-2023.Human vaccines & immunotherapeutics · 2026Article
- Nursing staff experiences of participating in digital therapeutic product development: a qualitative study.Frontiers in public health · 2026Article
- Optimizing the prevention of mother-to-child transmission of hepatitis B through integrated care models: a pilot study in Jiangsu Province, China.BMC public health · 2025Article
- Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China.Journal of clinical and translational hepatology · 2025Review
- A Multi-Regional Epidemiological Evaluation on Post-vaccination Serological Testing in Prevention of Vertical Transmission of Hepatitis B Virus - 10 Counties, 5 Provinces, China, 2019-2024.China CDC weekly · 2025Article
- [Recent advances in epidemiology, prevention and treatment of hepatitis B in China].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025Article
- 2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges.Hepatobiliary surgery and nutrition · 2025Review
- Investigation of Mother-to-Child Transmission of Hepatitis B in Yinchuan, China: Cross-Sectional Survey Study.JMIR public health and surveillance · 2024Article
- Improving integrated perinatal care for women with hepatitis B in China.BMJ (Clinical research ed.) · 2024Article
- Comprehensive approach to controlling chronic hepatitis B in China.Clinical and molecular hepatology · 2024Review
- Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China.Nature medicine · 2024Article
- Effect of prophylactic antiviral intervention on T cell immunity in hepatitis B virus-infected pregnant women.BMC pregnancy and childbirth · 2023Article
- Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022).Journal of clinical and translational hepatology · 2022Article
- Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.Emerging microbes & infections · 2021Article
- Hepatitis B prevalence in pregnant women in China: Progress and realities.The Lancet regional health. Western Pacific · 2021Article
- Prevention of Mother-to-Child Transmission of Hepatitis B Virus in the Western Pacific Region.Clinical liver disease · 2021Review
- [Management algorithm for prevention of mother-to-child transmission of hepatitis B virus (2021)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- [A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 12 institutions in 3 countries.
Xueru YinDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Guorong HanDepartment of Gynecology and Obstetrics, The Second Affiliated Hospital of the Southeast University, Nanjing, Jiangsu, China.
Hua ZhangDepartment of Obstetrics and Gynecology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Mei WangDepartment of Obstetrics and Gynecology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, China.
Wenjun ZhangDepartment of Obstetrics and Gynecology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Yunfei GaoDepartment of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Mei ZhongDepartment of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Xiaolan WangDepartment of Obstetrics, Jiujiang Maternal and Child Care Center, Jiujiang, Jiangxi, China.
Xiaozhu ZhongDepartment of Infectious Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Guojun ShenDepartment of Infectious Diseases, Third People's Hospital of Jiujiang, Jiujiang, Jiangxi, China.
Chuangguo YangDepartment of Infectious Diseases, The Third Affiliated Hospital of Southern Medical university, Guangzhou, Guangdong, China.
Huiyuan LiuDepartment of Severe Liver Diseases, Guangzhou Eighth People's Hospital, Guangzhou, Guangdong, China.
Zhihong LiuDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Po-Lin ChanWorld Health Organization/Western Pacific Regional Office (WPRO), Manila, Philippines.
Marc BulterysGlobal Hepatitis Programme, World Health Organization, Geneva, Switzerland.
Fuqiang CuiSchool of Public Health, Peking University, Beijing, China.
Hui ZhuangDepartment of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Zhihua LiuDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Jinlin HouDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Southern Medical University · CNNanfang Hospital · CNPeking University · CNThird Affiliated Hospital of Southern Medical University · CNCapital Medical University · CNGuangzhou Eighth People's Hospital · CNJiujiang First People's Hospital · CNJiujiang Maternal and Child Care Centres · CNPeople's Liberation Army No. 150 Hospital · CNSecond Affiliated Hospital of Nanjing Medical University · CNWorld Health Organization · CHWorld Health Organization Regional Office for the Western Pacific · PH
Funding
World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antiviral therapyHepatitis B virusImmunoprophylaxisMother-to-child transmissionShield Project
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.